Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Canadian Journal of Physiology and Pharmacology
|
January 7, 2010
Targeted production of proprotein convertase PC1 enhances mammary development and tumorigenesis in transgenic mice
Anne Blanchard, Barbara Iwasiow, Alison Yarmill, et al.
Stem Cell Reports
|
December 14, 2017
Breast Cancers Activate Stromal Fibroblast-Induced Suppression of Progenitors in Adjacent Normal Tissue
Sumanta Chatterjee, Pratima Basak, Edward Buchel, et al.
Virchows Archiv : an International Journal of Pathology
|
April 24, 2009
Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype
Anne A Blanchard, George P Skliris, Peter H Watson, et al.
Breast Cancer Research and Treatment
|
December 24, 2008
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas
George P Skliris, Brian G Rowan, Mariam Al-Dhaheri, et al.
Cancer Research
|
July 5, 2005
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer
Ethan D Emberley, Yulian Niu, Linda Curtis, et al.
Biochemical and Biophysical Research Communications
|
February 5, 2003
Identification of new human coding steroid receptor RNA activator isoforms
Ethan Emberley, Guo-Jian Huang, Mohammad K Hamedani, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 12, 2009
The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo
Leigh C Murphy, Georgios P Skliris, Brian G Rowan, et al.
Iscience
|
August 17, 2019
Paracrine Crosstalk between Fibroblasts and ER<sup>+</sup> Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth
Sumanta Chatterjee, Vasudeva Bhat, Alexei Berdnikov, et al.
Current Medicinal Chemistry
|
December 16, 2006
Targeting the EGFR pathway for cancer therapy
James B Johnston, Sri Navaratnam, Marshall W Pitz, et al.
Molecular Cancer Therapeutics
|
May 3, 2014
Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy
Samantha C Ruddy, Rosanna Lau, Miguel A Cabrita, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Canadian Journal of Physiology and Pharmacology
|
January 7, 2010
Targeted production of proprotein convertase PC1 enhances mammary development and tumorigenesis in transgenic mice
Anne Blanchard, Barbara Iwasiow, Alison Yarmill, et al.
Stem Cell Reports
|
December 14, 2017
Breast Cancers Activate Stromal Fibroblast-Induced Suppression of Progenitors in Adjacent Normal Tissue
Sumanta Chatterjee, Pratima Basak, Edward Buchel, et al.
Virchows Archiv : an International Journal of Pathology
|
April 24, 2009
Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype
Anne A Blanchard, George P Skliris, Peter H Watson, et al.
Breast Cancer Research and Treatment
|
December 24, 2008
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas
George P Skliris, Brian G Rowan, Mariam Al-Dhaheri, et al.
Cancer Research
|
July 5, 2005
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer
Ethan D Emberley, Yulian Niu, Linda Curtis, et al.
Biochemical and Biophysical Research Communications
|
February 5, 2003
Identification of new human coding steroid receptor RNA activator isoforms
Ethan Emberley, Guo-Jian Huang, Mohammad K Hamedani, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 12, 2009
The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo
Leigh C Murphy, Georgios P Skliris, Brian G Rowan, et al.
Iscience
|
August 17, 2019
Paracrine Crosstalk between Fibroblasts and ER<sup>+</sup> Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth
Sumanta Chatterjee, Vasudeva Bhat, Alexei Berdnikov, et al.
Current Medicinal Chemistry
|
December 16, 2006
Targeting the EGFR pathway for cancer therapy
James B Johnston, Sri Navaratnam, Marshall W Pitz, et al.
Molecular Cancer Therapeutics
|
May 3, 2014
Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy
Samantha C Ruddy, Rosanna Lau, Miguel A Cabrita, et al.
Page
of 6